BerandaREGN • NASDAQ
add
Regeneron Pharmaceuticals Inc
$738,00
Setelah Jam Perdagangan Normal:(0,00%)0,00
$738,00
Tutup: 22 Nov, 16.38.47 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$744,50
Rentang hari
$737,63 - $751,40
Rentang tahun
$735,95 - $1.211,20
Kapitalisasi pasar
81,10Â M USD
Volume Rata-Rata
820,44Â rb
Rasio P/E
18,26
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 3,72Â M | 10,65% |
Biaya operasional | 714,40Â jt | 11,62% |
Laba bersih | 1,34Â M | 33,02% |
Margin laba bersih | 36,03 | 20,22% |
Penghasilan per saham | 12,46 | 7,51% |
EBITDA | 1,37Â M | 3,72% |
Tarif pajak efektif | 10,21% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 9,80Â M | -1,18% |
Total aset | 37,44Â M | 16,41% |
Total liabilitas | 8,12Â M | 11,81% |
Total ekuitas | 29,33 M | — |
Saham yang beredar | 107,59 jt | — |
Harga terhadap nilai buku | 2,74 | — |
Tingkat pengembalian aset | 8,46% | — |
Tingkat pengembalian modal | 9,88% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 1,34Â M | 33,02% |
Kas dari operasi | 1,29Â M | 15,88% |
Kas dari investasi | -574,40Â jt | -15,74% |
Kas dari pembiayaan | -634,00Â jt | -55,66% |
Perubahan kas bersih | 83,60Â jt | -60,29% |
Arus kas bebas | 761,49Â jt | 22,14% |
Tentang
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Didirikan
1988
Kantor pusat
Situs
Karyawan
14.165
